In part one we looked at a lawsuit being brought by Jaclyn Bjorklund against Novo Nordisk (maker of Semaglutide - brand names Ozempic/Rybelsus/Wegovy) and Eli Lilly (maker of Tirzepatide - brand names Mounjaro/Zepbound) for the severe gastrointestinal side effects she experienced after taking Ozempic and then Mounjaro for type 2 diabetes. At the end I made the point that, for some people, the negative side effects don’t end when they stop taking the medications and for others, the damage has been done.
That brings us to Juanita Gantt.